Krsnaa Diagnostics Approves Sale of Diagnostic Equipment for up to ₹120 Cr

Krsnaa Diagnostics Limited's Board of Directors has approved the sale of identified diagnostic equipment for an aggregate consideration of up to ₹120 crore. This strategic move is part of the company's initiative to optimize its asset portfolio, enhance capital efficiency, and unlock value from non-core assets. The sale is intended to facilitate capital recycling towards the core diagnostic business and growth opportunities, aiming to improve asset utilization, ROCE, and strengthen the balance sheet. The transaction involves freehold assets not subject to lender security and is not expected to materially impact the company's P&L or ongoing operations. The Operations Committee has been authorized to finalize the transaction terms.